Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients

Brain Research

Volumn 917, Issue 1, 2001, Pages 97-104

  Shibata, Noriyuki ^a   Nagai, Ryoji ^b   Uchida, Koji ^c   Horiuchi, Seikoh ^b   Yamada, Satoshi ^d   Hirano, Asao ^e   Kawaguchi, Motoko ^a   Yamamoto, Tomoko ^a   Sasaki, Shoichi ^a   Kobayashi, Makio ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

^d NOF Corporation   (Japan)

^e MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Amyotrophic lateral sclerosis; Astrocyte; Lipid peroxidation; Microglia; Motor neuron; Protein glycoxidation

Indexed keywords

4 HYDROXYNONENAL; 6 N CARBOXYETHYLLYSINE; 6 N CARBOXYMETHYLLYSINE; ARGPYRIMIDINE; BIOLOGICAL MARKER; CROTONALDEHYDE; HISTIDINE; IMIDAZOLONE; LIPID; LYSINE; PROTEIN; PYRRALINE; UNCLASSIFIED DRUG;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASTROCYTE; FEMALE; GLIA CELL; GLYCOLYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIPID PEROXIDATION; MACROPHAGE; MALE; MICROGLIA; MOTONEURON; NERVE CELL DEGENERATION; NEUROPIL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SPINAL CORD;

AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTES; FEMALE; GLUCOSE; HUMANS; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDES; MACROPHAGES; MALE; MICROGLIA; MIDDLE AGED; MOTOR NEURONS; OXIDATION-REDUCTION; PROTEINS; SPINAL CORD;

EID: 0035955478     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)02926-2     Document Type: Article

References (53)

1. ε-(Carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins
2. Increased expression of the proinflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis
3. 4-Hydroxynonenal, a lipid peroxidation product, impairs glutamate transport in cortical astrocytes
4. Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease
5. Induction of liver tumors in F344 rats by crotonaldehyde
6. Lipid peroxidation as a potential endogeneous source for the formation of exocyclic DNA adducts
7. 2-propanodeoxyguanosine adducts
8. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
9. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis
10. Evidence for DNA damage in amyotrophic lateral sclerosis
11. Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein
12. ε-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions
13. Effects of oxygen and transtion metals on the advanced Maillard reaction of proteins with glucose
14. Endogeneous formation of protein adducts with carcinogenic aldehydes. Implication for oxidative stress
15. Crotonaldehyde
16. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: Supression of mitochondrial dysfunction
17. Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system
18. Neurotoxicity of methylglyoxal and 3-deoxyglucosone on cultured cortical neurons: Synergism between glycation and oxidative stress, possibly involved in neurodegenerative diseases
19. Identification of advanced glycation end products of the Maillard reaction in Pick's disease
20. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis
21. 4-Hydroxy-2-nonenal, the end product of lipid peroxidation, is a specific inducer of cyclooxygenase-2 gene expression
22. Immunohistochemical distribution and quantative biochemical detection of advanced glycation end products in fetal to adult rats and in rats with streptozotocin-induced diabetes
23. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide
24. Amyloid β-peptide impairs glucose transport in hippocampal and cortical neurons: Involvement of membrane lipid peroxidation
25. 4-Hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau
26. Advanced glycation end products induce apoptosis and procoagulant activity in cultured human umbilical vein endothelial cells
27. Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline
28. Alterations in nonenzymatic biochemistry in uremia: Origin and significance of 'carbonyl stress' in long-term uremic complications
29. E-4-Hydroxy-2-noneal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures
30. ε-(carboxymethyl)lysine formation from Amadori product
31. ε-(carboxymethyl)lysine, one of the major AGE-structures
32. ε-(carboxymethyl)lysine, an advanced glycation end product, by glyoxal and 3-deoxyglucosone in cultured rat sensory neurona
33. Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients
34. Induction of apoptotic cell death by methyglyoxal and 3-deoxyglucosone in macrophage-derived cell lines
35. Methylglyoxal modification of protein
36. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients
37. The lipid peroxidation product of 4-hydroxynonenal impairs glutamate and glucose transport and choline acetyltransferase activity in NSC-19 motor neuron cells
38. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis
39. Oxidative damage to protein in sporadic motor neuron disease spinal cord
40. Nonoxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation
41. Superoxide dismutase-1 mutation-related neurotoxicity in familial amyotrophic lateral sclerosis
42. Selective vulnerability of spinal motor neurons to reactive dicarbonyl compounds, intermediate products of glycation, in vitro: Implication of inefficient glutathione system in spinal motor neurons
43. Neurotoxicity of advanced glycation end-products for cultured cortical neurons
44. Inhibitory effect of nonenzymatic glycosylation on ubiquitination and ubiquitin-mediated degradatio of lysozyme
45. Formation of glyoxal, methyglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose
46. The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct
47. Activation of stress signaling pathways by the end product of lipid peroxidation
48. Role of reactive aldehyde in cardiovascular diseases
49. Identification of crotonaldehyde as a hepatic microsomal metabolite formed by α-hydroxylation of the carcinogen N-nitrosopyrrolidine
50. Identification of paraldol-deoxyguanosine adducts in DNA reacted with crotonaldehyde
51. Mechanism of autoxidative glycosylation: Identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose
52. Non-enzymatic glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide
53. Amyloid β-peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: A proinflammatory pathway in Alzheimer disease